Market.us announces the publication of its most recently generated research report titled, “Spain Benzocaine Market by Type (Benzocaine with 98% Purity, Benzocaine with 99% Purity, and Others), By Concentration (Below 20% and Above 20%), By Application (Cosmetics, Anesthetic, and Other Application) and by Region – Global Forecast to 2029.”, which offers a holistic view of the Spain Benzocaine Market through systematic segmentation that covers every aspect of the target market.

The Spain Benzocaine Market is projected to be US$ 3.7 Mn in 2019 to reach US$ 5.4 Mn by 2029 at a CAGR of 3.9%.

Benzocaine was first introduced in 1890 by the German chemist Eduard Ritsert and later announced to the market in 1902 named as Anaesthesia. Benzocaine is a commercially available local anaesthetic. It is an amino ester which is used in a variety of settings including preparation for infiltrative anaesthesia, dental procedures, and minor traumas. The major purpose of benzocaine is to reduce minor pains caused by needle penetration. This is an allergen for more significant pain control and to reduce the anxiety of the patients. Benzocaine is a standardized chemical allergen that provides relief from a various conditions such as discomfort caused by minor skin irritation, throat, soreness, teething pain, sunburn, ingrown toenails, haemorrhoids, vaginal or rectal irritation and other pain on the surface of the body.

The presence of a large number of pharmaceutical companies providing benzocaine in various forms such as gels, sprays, liquids, lozenges, etc. in a range of dosages for various age groups is another factor expected to fuel the growth of the target market. The benzocaine drug is available at a very economical price which is also gaining traction among consumers and is anticipated to propel the growth of the market.

Spain Benzocaine Market Revenue (US$ Mn), 2019–2029 

FDA reported more than 400 adverse cases related to the use of benzocaine since 1971. As per the report, benzocaine contains a product that should not be used for the treatment of infants and children younger than 2 years. The FDA has found that the products delivered serious threats and have no benefit in treating sore gums in infants due to teething. Moreover, the FDA has warned the consumer against the use of benzocaine products. Therefore, restricted regulations against benzocaine are expected to hamper the growth of the market in the coming years.

The benzocaine market is segmented based on product type, concentration type, and application. On the basis of product type market is further segmented into Benzocaine with 98% purity, Benzocaine with 99% purity and others. Among these, benzocaine with 98% is expected to gain the highest share in the market.  Based on the concentration type, the market is further divided into below 20% and above 20%. Among these, below 20% segment is account for the major share. Based on application, the market is segmented into cosmetic, anaesthetic and other concentrations. Among these, the anaesthetic market segment is anticipated to contribute a major share in the Spain market.

Spain Benzocaine Market Share by Product Type, 2019

The research report on the Spain Benzocaine Market includes profiles of some of the major companies such as Aceto Corporation, Thermo Fisher Scientific Inc., Beutlich Pharmaceuticals LLC, Indofine Chemical Company, Jinzhou Jiutai Pharmaceutical Co. Ltd., Merck KGaA, Tokyo Chemical Industry Co., Ltd.

Key Market Segments

Type

• Benzocaine with 98% purity
• Benzocaine with 99% purity

Application

• Below 20%
• Above 20%

Key Market Players included in the report:

• Aceto Corporation
• Thermo Fisher Scientific Inc.
• Beutlich Pharmaceuticals LLC
• Indofine Chemical Company
• Jinzhou Jiutai Pharmaceutical Co. Ltd.
• Merck KGaA
• Tokyo Chemical Industry Co.Ltd.